Director/PDMR Shareholding
RNS Number : 2939ARentokil Initial PLC23 October 2026
23 October 2026
Rentokil Initial plc
Notification of a transaction by a Person Discharging Managerial Responsibilities
and their Person Closely Associated
Rentokil Initial plc (the 'Company') hereby announces that on 22 October 2026 The Thérèse M. Esperdy Revocable Trust, a Person Closely Associated ('PCA') with Thérèse Esperdy, Chair, purchased 10,881 American Depositary Shares ('ADSs') in the Company at a price of USD22.9102 per ADS.
The notification set out below is provided in accordance with the requirements of Article 19 of the UK Market Abuse Regulation.
Rachel Canham
Group General Counsel & Company Secretary
Tel: +44 (0)1293 858000
1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
The Thérèse M. Esperdy Revocable Trust
2
Reason for the notification
a)
Position/status
PCA of Thérèse Esperdy, Chair
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
Rentokil Initial plc
b)
LEI
549300VN4WV7Z6T14K68
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Identification code
Rentokil Initial plc American Depositary Shares
CUSIP: 760125104
b)
Nature of the transaction
Purchase of American Depositary Shares
c)
Price(s) and volume(s)
Price(s)
Volume(s)
USD22.9102
10,881
d)
Aggregated information
- Aggregated volume
- Total price
10,811
USD249,285.8862
e)
Date of the transaction
2026-10-22
f)
Place of the transaction
New York Stock Exchange (XNYS)
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.ENDDSHBDBDGLUDDGLX
Recent news on Rentokil Initial
See all newsDirector/PDMR Shareholding
UK stocks slip as banks drag; earnings in focus
Rentokil announces $200 million buyback; quarterly revenue rises on improving North America business
Rentokil jumps after quarterly revenue growth, sets $200 million buyback
Brief: Rentokil Initial Says Sarah Sergeant Will Be CFO On An Interim Basis
